1. Home
  2. STTK vs ATLO Comparison

STTK vs ATLO Comparison

Compare STTK & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.37

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$27.63

Market Cap

239.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
ATLO
Founded
2016
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
239.2M
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
STTK
ATLO
Price
$6.37
$27.63
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$7.60
N/A
AVG Volume (30 Days)
657.3K
37.3K
Earning Date
03-05-2026
04-16-2026
Dividend Yield
N/A
2.90%
EPS Growth
53.02
8.03
EPS
N/A
0.38
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$72.55
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$16.09
52 Week High
$6.31
$28.35

Technical Indicators

Market Signals
Indicator
STTK
ATLO
Relative Strength Index (RSI) 73.85 58.69
Support Level $1.85 $25.95
Resistance Level N/A $28.07
Average True Range (ATR) 0.40 0.71
MACD 0.01 0.03
Stochastic Oscillator 79.43 82.20

Price Performance

Historical Comparison
STTK
ATLO

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About ATLO Ames National Corporation

Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.

Share on Social Networks: